Delivery Order SPE2DB22D1017-SPE2DB25FF7JC

Award Date 3/10/25
Potential Completion Date 3/11/25
Potential Value $19K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $47,236.94 firm-fixed-price delivery order is for the pharmaceutical product Verzenio 150 mg tablets. The contract has an ultimate completion date of November 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a $14,490.56 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Verzenio 150 mg tablets and has a performance period through November 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Verzenio 50 mg tablets. The $20,678.27 firm-fixed-price delivery order has a completion date of February 13, 2025. The contract is not designated as a set-aside award. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,459.90 Firm Fixed Price Delivery Order contract is for the supply of VERZENIO 50 MG TABLET UU 14S, a pharmaceutical product. The contract has an ultimate completion date of January 9, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for medical supplies and pharmaceutical products provided by AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to the Defense Logistics Agency (DLA). The award, valued at $8,505.88, is a delivery order contract for the supply of Verzenio 150 mg tablets. The contract has an ultimate completion date of January 16, 2025 and is a firm fixed-price agreement. AmerisourceBergen holds a larger $999,999,999 Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order worth $10,933.54 with a firm fixed price pricing type and a completion date of July 5, 2024. The contract is for the provision of medical products, specifically the drug Verzenio 50 mg tablet, to support military healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,055.59 firm fixed-price delivery order contract is for the supply of Verzenio 100 mg tablets to support federal healthcare programs. The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,273.57 firm-fixed-price contract covers the delivery of the drug Verzenio 150 mg tablets. The contract has a completion date of June 10, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,586.12 Firm Fixed Price Delivery Order is for VERZENIO 150 MG TABLET, a pharmaceutical product. The contract has an ultimate completion date of October 27, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of various pharmaceutical products, including Verzenio 100 mg tablets. The contract, valued at $7,449.28, is a firm fixed-price delivery order with a completion date of December 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF7JC
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,851.93, provides the DLA with various pharmaceutical products including the drug Verzenio 50 mg tablet. The contract has an ultimate completion date of March 11, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for federal agencies and beneficiaries.

Generated 6/9/25, 9:52 AM